AAAAAA

   
Results: 1-18 |
Results: 18
96-HOUR INFUSIONAL PACLITAXEL AS SALVAGE THERAPY OF OVARIAN-CANCER PATIENTS PREVIOUSLY FAILING TREATMENT WITH 3-HOUR OR 24-HOUR PACLITAXEL INFUSION REGIMENS
Authors: MARKMAN M ROSE PG JONES E HOROWITZ IR KENNEDY A WEBSTER K BELINSON J FUSCO N FLUELLEN L KULP B PETERSON G MCGUIRE WP
Citation: M. Markman et al., 96-HOUR INFUSIONAL PACLITAXEL AS SALVAGE THERAPY OF OVARIAN-CANCER PATIENTS PREVIOUSLY FAILING TREATMENT WITH 3-HOUR OR 24-HOUR PACLITAXEL INFUSION REGIMENS, Journal of clinical oncology, 16(5), 1998, pp. 1849-1851
PACLITAXEL ADMINISTRATION TO GYNECOLOGIC CANCER-PATIENTS WITH MAJOR CARDIAC RISK-FACTORS
Authors: MARKMAN M KENNEDY A WEBSTER K KULP B PETERSON G BELINSON J
Citation: M. Markman et al., PACLITAXEL ADMINISTRATION TO GYNECOLOGIC CANCER-PATIENTS WITH MAJOR CARDIAC RISK-FACTORS, Journal of clinical oncology, 16(11), 1998, pp. 3483-3485
EVIDENCE THAT A TREATMENT-FREE INTERVAL OF LESS-THAN 6 MONTHS DOES NOT EQUATE WITH CLINICALLY DEFINED PLATINUM RESISTANCE IN OVARIAN-CANCEROR PRIMARY PERITONEAL CARCINOMA
Authors: MARKMAN M KENNEDY A WEBSTER K KULP B PETERSON G BELINSON J
Citation: M. Markman et al., EVIDENCE THAT A TREATMENT-FREE INTERVAL OF LESS-THAN 6 MONTHS DOES NOT EQUATE WITH CLINICALLY DEFINED PLATINUM RESISTANCE IN OVARIAN-CANCEROR PRIMARY PERITONEAL CARCINOMA, Journal of cancer research and clinical oncology, 124(6), 1998, pp. 326-328
LYSOPHOSPHATIDIC ACID AS A POTENTIAL BIOMARKER FOR OVARIAN AND OTHER GYNECOLOGIC CANCERS
Authors: XU Y SHEN ZZ WIPER DW WU MZ MORTON RE ELSON P KENNEDY AW BELINSON J MARKMAN M CASEY G
Citation: Y. Xu et al., LYSOPHOSPHATIDIC ACID AS A POTENTIAL BIOMARKER FOR OVARIAN AND OTHER GYNECOLOGIC CANCERS, JAMA, the journal of the American Medical Association, 280(8), 1998, pp. 719-723
LOW-DOSE ORAL GRANISETRON (1 MG) PLUS INTRAVENOUS DEXAMETHASONE - EFFICACY IN GYNECOLOGIC CANCER-PATIENTS RECEIVING CARBOPLATIN-BASED CHEMOTHERAPY
Authors: MARKMAN M KENNEDY A WEBSTER K KULP B PETERSON G BELINSON J
Citation: M. Markman et al., LOW-DOSE ORAL GRANISETRON (1 MG) PLUS INTRAVENOUS DEXAMETHASONE - EFFICACY IN GYNECOLOGIC CANCER-PATIENTS RECEIVING CARBOPLATIN-BASED CHEMOTHERAPY, Gynecologic oncology (Print), 71(1), 1998, pp. 113-115
PHASE-2 TRIAL OF SINGLE-AGENT IFOSFAMIDE MESNA IN PATIENTS WITH PLATINUM/PACLITAXEL REFRACTORY OVARIAN-CANCER WHO HAVE NOT PREVIOUSLY BEEN TREATED WITH AN ALKYLATING AGENT/
Authors: MARKMAN M KENNEDY A SUTTON G HURTEAU J WEBSTER K PETERSON G KULP B BELINSON J
Citation: M. Markman et al., PHASE-2 TRIAL OF SINGLE-AGENT IFOSFAMIDE MESNA IN PATIENTS WITH PLATINUM/PACLITAXEL REFRACTORY OVARIAN-CANCER WHO HAVE NOT PREVIOUSLY BEEN TREATED WITH AN ALKYLATING AGENT/, Gynecologic oncology (Print), 70(2), 1998, pp. 272-274
PHASE-2 TRIAL OF MODERATELY HIGH-DOSE SINGLE-AGENT MITOXANTRONE IN PLATINUM AND PACLITAXEL-REFRACTORY OVARIAN-CANCER
Authors: MARKMAN M LICHTMAN SM HOMESLEY H KENNEDY A WEBSTER K ERNST S OMURA G BELINSON J
Citation: M. Markman et al., PHASE-2 TRIAL OF MODERATELY HIGH-DOSE SINGLE-AGENT MITOXANTRONE IN PLATINUM AND PACLITAXEL-REFRACTORY OVARIAN-CANCER, Gynecologic oncology (Print), 70(1), 1998, pp. 123-126
SIMPLIFIED REGIMEN FOR THE PREVENTION OF PACLITAXEL-ASSOCIATED HYPERSENSITIVITY REACTIONS
Authors: MARKMAN M KENNEDY A WEBSTER K PETERSON G KULP B BELINSON J
Citation: M. Markman et al., SIMPLIFIED REGIMEN FOR THE PREVENTION OF PACLITAXEL-ASSOCIATED HYPERSENSITIVITY REACTIONS, Journal of clinical oncology, 15(12), 1997, pp. 3517-3517
LOW-DOSE INTRAVENOUS ONDANSETRON (8 MG) PLUS DEXAMETHASONE - AN EFFECTIVE REGIMEN FOR THE CONTROL OF CARBOPLATIN-INDUCED EMESIS
Authors: MARKMAN M KENNEDY A WEBSTER K PETERSON G KULP B BELINSON J
Citation: M. Markman et al., LOW-DOSE INTRAVENOUS ONDANSETRON (8 MG) PLUS DEXAMETHASONE - AN EFFECTIVE REGIMEN FOR THE CONTROL OF CARBOPLATIN-INDUCED EMESIS, Journal of cancer research and clinical oncology, 123(4), 1997, pp. 224-226
CARBOPLATIN PLUS PACLITAXEL IN THE TREATMENT OF GYNECOLOGIC MALIGNANCIES - THE CLEVELAND CLINIC EXPERIENCE
Authors: MARKMAN M KENNEDY A WEBSTER K KULP B PETERSON G BELINSON J
Citation: M. Markman et al., CARBOPLATIN PLUS PACLITAXEL IN THE TREATMENT OF GYNECOLOGIC MALIGNANCIES - THE CLEVELAND CLINIC EXPERIENCE, Seminars in oncology, 24(5), 1997, pp. 26-29
LEUPROLIDE IN THE TREATMENT OF ENDOMETRIAL CANCER
Authors: MARKMAN M KENNEDY A WEBSTER K PETERSON G KULP B BELINSON J
Citation: M. Markman et al., LEUPROLIDE IN THE TREATMENT OF ENDOMETRIAL CANCER, Gynecologic oncology, 66(3), 1997, pp. 542-542
CONTINUED CHEMOSENSITIVITY TO CISPLATIN CARBOPLATIN IN OVARIAN-CARCINOMA DESPITE TREATMENT WITH MULTIPLE PRIOR PLATINUM-BASED REGIMENS/
Authors: MARKMAN M KENNEDY A WEBSTER K KULP B PETERSON G BELINSON J
Citation: M. Markman et al., CONTINUED CHEMOSENSITIVITY TO CISPLATIN CARBOPLATIN IN OVARIAN-CARCINOMA DESPITE TREATMENT WITH MULTIPLE PRIOR PLATINUM-BASED REGIMENS/, Gynecologic oncology, 65(3), 1997, pp. 434-436
EVALUATION OF LYSOPHOSPHATIDIC ACID (LPA) AS A DIAGNOSTIC MARKER FOR OVARIAN AND OTHER GYNECOLOGICAL CANCERS
Authors: SHEN Z WU M WIPER DW MORTON RE KENNEDY AW BELINSON J MARKMAN M CASEY G XU Y
Citation: Z. Shen et al., EVALUATION OF LYSOPHOSPHATIDIC ACID (LPA) AS A DIAGNOSTIC MARKER FOR OVARIAN AND OTHER GYNECOLOGICAL CANCERS, Clinical chemistry, 43, 1997, pp. 577-577
CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF MESNA TO PREVENT IFOSFAMIDE-INDUCED HEMORRHAGIC CYSTITIS
Authors: MARKMAN M KENNEDY A WEBSTER K KULP B PETERSON G BELINSON J
Citation: M. Markman et al., CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF MESNA TO PREVENT IFOSFAMIDE-INDUCED HEMORRHAGIC CYSTITIS, Seminars in oncology, 23(3), 1996, pp. 97-98
PACLITAXEL DELIVERED AS A 3-HR INFUSION WITH CISPLATIN IN PATIENTS WITH GYNECOLOGIC CANCERS - UNEXPECTED INCIDENCE OF NEUROTOXICITY
Authors: CONNELLY E MARKMAN M KENNEDY A WEBSTER K KULP B PETERSON G BELINSON J
Citation: E. Connelly et al., PACLITAXEL DELIVERED AS A 3-HR INFUSION WITH CISPLATIN IN PATIENTS WITH GYNECOLOGIC CANCERS - UNEXPECTED INCIDENCE OF NEUROTOXICITY, Gynecologic oncology, 62(2), 1996, pp. 166-168
CONTROL OF CARBOPLATIN-INDUCED EMESIS WITH A FIXED LOW-DOSE OF GRANISETRON (0.5 MG) PLUS DEXAMETHASONE
Authors: MARKMAN M KENNEDY A WEBSTER K KULP B PETERSON G BELINSON J
Citation: M. Markman et al., CONTROL OF CARBOPLATIN-INDUCED EMESIS WITH A FIXED LOW-DOSE OF GRANISETRON (0.5 MG) PLUS DEXAMETHASONE, Gynecologic oncology, 60(3), 1996, pp. 435-437
DETECTION OF BRCA1 MUTATIONS BY THE PROTEIN TRUNCATION TEST
Authors: PLUMMER SJ ANTONCULVER H WEBSTER L NOBLE B LIAO S KENNEDY A BELINSON J CASEY G
Citation: Sj. Plummer et al., DETECTION OF BRCA1 MUTATIONS BY THE PROTEIN TRUNCATION TEST, Human molecular genetics, 4(10), 1995, pp. 1989-1991
PACLITAXEL (T) GIVEN AS A 3-HOUR (HR) INFUSION ALONG WITH CISPLATIN (C) IN PATIENTS (PTS) WITH GYNECOLOGIC CANCERS
Authors: MARKMAN M KENNEDY A WEBSTER K KULP B PETERSON G BELINSON J
Citation: M. Markman et al., PACLITAXEL (T) GIVEN AS A 3-HOUR (HR) INFUSION ALONG WITH CISPLATIN (C) IN PATIENTS (PTS) WITH GYNECOLOGIC CANCERS, Clinical research, 42(2), 1994, pp. 10000342-10000342
Risultati: 1-18 |